Hematology TimesTeam finds no evidence that gadolinium causes neurologic harmDecember 1, 2017Related Issues
The Journal of Community and Supportive OncologyIt's all about the care: new takes on access, quality, consolidation, and outcomesDecember 1, 2017Patient & Survivor Care
Hematology NewsASCT or novel therapies in early relapsing follicular lymphoma?November 30, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology TimesStudy reveals potential target for AML treatmentNovember 30, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesInhibitor exhibits activity against range of lymphomasNovember 30, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesFDA grants drug orphan designation for AML, MDSNovember 30, 2017AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Hematology NewsDrug prices a key focus of Senate HELP examination of Azar nominationNovember 29, 2017Business of MedicinePractice Management
Hematology NewsHealthCare.gov seeing more action this fallNovember 29, 2017Business of MedicinePractice Management
Hematology NewsEmpagliflozin’s heart failure benefits linked to volume dropNovember 29, 2017Bleeding Disorders
Oncology PracticeReal-world data support extended cervical cancer screening intervalNovember 29, 2017Gynecologic Cancer
Hospital Physician: Hematology/OncologyHairy Cell LeukemiaNovember 29, 2017Leukemia, Myelodysplasia, Transplantation
